Guidance Recap Podcast | Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments

Update: 2022-06-29

Description

Guidance Recap Podcast: Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Guidance Recap Podcast | Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development

2024-10-1612:09

Guidance Recap Podcast | Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies

2024-09-1818:04

Guidance Recap Podcast | Digital Health Technologies for Remote Data Acquisition in Clinical Investigations

2024-07-2425:47

Guidance Recap Podcast | Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics

2024-07-1514:56

Guidance Recap Podcast | E19 A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-approval or Post-approval Clinical Trials

2024-04-2212:15

Guidance Recap Podcast | Pharmacokinetics Study Design Considerations in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing

2024-04-1612:04

Guidance Recap Podcast | Clinical Pharmacology Considerations for Antibody-Drug Conjugates

2024-03-2612:02

Guidance Recap Podcast | Master Protocols for Drug and Biological Product Development

2023-12-2115:13

Guidance Recap Podcast | Drug-Drug Interaction Assessment for Therapeutic Proteins

2023-12-1113:29

Guidance Recap Podcast | Translation of Good Laboratory Practice Study Reports: Questions and Answers

2023-11-2113:39

Guidance Recap Podcast | Benefit-Risk Assessment for New Drug and Biologic Products

2023-10-1912:55

Guidance Recap Podcast | Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products

2023-05-2507:34

Guidance Recap Podcast | Use of Whole Slide Imaging in Nonclinical Toxicology Studies: Questions and Answers

2023-05-2411:22

Guidance Recap Podcast | Enhancing the Diversity of Clinical Trial Populations—Eligibility Criteria, Enrollment Practices, and Trial Designs

2023-05-2214:14

Guidance Recap Podcast | Podcast for Patients — Enhancing the Diversity of Clinical Trial Populations—Eligibility Criteria, Enrollment Practices, and Trial Designs

2023-05-1925:19

Guidance Recap Podcast | Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study Design, Data Analysis, and Clinical Implications

2023-05-1512:45

Guidance Recap Podcast | Multiple Endpoints in Clinical Trials

2022-10-2011:49

Guidance Recap Podcast | Ethical Considerations for Clinical Investigations of Medical Products Involving Children

2022-09-2314:52

Guidance Recap Podcast | General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products

2022-07-2608:41

Guidance Recap Podcast | Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments

2022-06-2911:29

00:00

1.0x

Guidance Recap Podcast | Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments

U.S. Food and Drug Administration

#box-pro-ellipsis-173225217994334{-webkit-line-clamp:2;}Guidance Recap Podcast | Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments

Guidance Recap Podcast | Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments

U.S. Food and Drug Administration

Guidance Recap Podcast | Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments